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Tissue clarification has been recently proposed to allow deep tissue imaging without
light scattering. The clarification parameters are somewhat arbitrary and dependent
on tissue type, source and dimension: every laboratory has its own protocol, but a
quantitative approach to determine the optimum clearing time is still lacking. Since the
use of transgenic mouse lines that express fluorescent proteins to visualize specific cell
populations is widespread, a quantitative approach to determine the optimum clearing
time for genetically labeled neurons from thick murine brain slices using CLARITY2 is
described. In particular, as the main objective of the delipidation treatment is to clarify
tissues, while limiting loss of fluorescent signal, the “goodness” of clarification was
evaluated by considering the bulk tissue clarification index (BTCi) and the fraction of the
fluorescent marker retained in the slice as easily quantifiable macroscale parameters.
Here we describe the approach, illustrating an example of how it can be used to
determine the optimum clearing time for 1mm-thick cerebellar slice from transgenic
L7GFP mice, in which Purkinje neurons express the GFP (green fluorescent protein) tag.
To validate the method, we evaluated confocal stacks of our samples using standard
image processing indices (i.e., the mean pixel intensity of neurons and the contrast-to
-noise ratio) as figures of merit for image quality. The results show that detergent-based
delipidation for more than 5 days does not increase tissue clarity but the fraction of GFP
in the tissue continues to diminish. The optimum clearing time for 1mm-thick slices was
thus identified as 5 days, which is the best compromise between the increase in light
penetration depth due to removal of lipids and a decrease in fluorescent signal as a
consequence of protein loss: further clearing does not improve tissue transparency, but
only leads to more protein removal or degradation. The rigorous quantitative approach
described can be generalized to any clarification method to identify the moment when
the clearing process should be terminated to avoid useless protein loss.
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INTRODUCTION
One of the challenges of modern neuroscience is to map the
architecture of neural circuits in the mammalian brain, in order
to delineate the so-called “Connectome” (Van Essen and Ugurbil,
2012), tracing the information pathways through axons and
dendrites of neurons in their native three-dimensional (3D)
arrangement.
The main obstacle for this kind of study is the presence
of lipids, which cause light scattering, limit the depth of light
penetration, and constitute an antibody-impermeable barrier.
Even using two-photon microscopy, it is impossible to penetrate
brain samples more than a few hundred microns (Oheim
et al., 2001), which is insufficient for reconstructing large
brain projections or complete neural populations (Chung and
Deisseroth, 2013).
To overcome these limits, a number of optical clearing or
delipidation approaches have been developed to render the whole
brain transparent so that it can be analyzed without sectioning
(Hama et al., 2011; Ertürk et al., 2012; Ke et al., 2013; Kuwajima
et al., 2013; Richardson and Lichtman, 2015). Among these,
the CLARITY method, pioneered and disseminated through
forums and Wiki pages by Deisseroth’s group (i.e., http://forum.
claritytechniques.org/), has captured the imagination of many
researchers and is currently discussed and debated widely (Chung
and Deisseroth, 2013; Chung et al., 2013; Tomer et al., 2014).
To date about 20 new papers on CLARITY and its variations
have been published and a number of them are dedicated to
the optimization or simplification of the experimental set up
(Lee et al., 2014; Epp et al., 2015; Esposito and Nikitichev, 2015;
Zheng and Rinaman, 2015). In fact, despite the plethora of virtual
discussion groups, the method remains substantially heuristic
due to the large number of steps involved and the ensemble of
variables which contribute to the tissue delipidation process. For
instance, tissue clearing is evaluated by visible inspection and is
thus prone to observer bias. Furthermore, the mechanisms of
tissue fixing and clarification remain elusive, making it almost
impossible to standardize CLARITY for rigorous quantitative
studies.
After Chung et al.’s seminal report (Chung et al., 2013), a
simplified diffusion based method, CLARITY2, was proposed
by Poguzhelskaya et al. (2014) to clarify 1–1.5mm thick slices.
CLARITY2 does not necessitate the use of the electrophoretic
chamber—probably the most time consuming and difficult step
of the whole procedure. The passive clarity technique (PACT) is
very similar to CLARITY2 (Yang et al., 2014). Both approaches
can be very useful when it is not necessary to achieve the full
potential of CLARITY to delipidate an intact brain, focusing
the study only on a brain sub-region or on a specific neuronal
population (i.e., Purkinje cells in the cerebellar layers). However,
despite their excellent contribution to brain imaging, even passive
clearing methods combine a large number of variables (i.e., slice
thickness, reagent concentrations, clearing times) leaving much
to trial and error.
Like CLARITY, CLARITY2 involves protein and structural
fixation through the use of formaldehyde and an acrylamide
based gel, followed by solubilisation of lipids using sodium
dodecyl sulfate (SDS) in the so-called clearing solution. The
removal of tissue lipids reduces tissue opacity, but is inevitably
accompanied by a non-specific loss of inter- and extra-cellular
components. Protein loss is in fact unavoidable during tissue
clarification, for example Chung et al.’s original paper (Chung
et al., 2013) reports an 8% decrease in protein content, albeit
some scientists on the CLARITY forum claim complete loss
of GFP signal (http://forum.claritytechniques.org/discussion/32/
loss-of-gfp-signal). Although, light can propagate further into
a highly transparent clarified tissue, there is less probability
of exciting fluorescence in such samples; hence the effective
measured signal is reduced.
Mouse lines are successfully and widely used to visualize
specific cell populations in the brain by the transgenic
expression of fluorescent proteins (Abe and Fujimori, 2013). In
genetically labeled tissue, clarification for imaging the 3D cellular
architecture can be regarded as a trade-off between the increase
in light penetration depth due to delipidation and a decrease
in phenotypic emission signal as a consequence of protein loss
through solubilisation or degradation.
To determine the best compromise between transparency and
fluorescent signal, an experimental method was developed for
optimization and standardization of the CLARITY2 protocol.
In particular, keeping all reagent concentrations as established
by Chung et al. (2013) constant, we define an approach to
macroscopically assess the delipidation efficacy as a function
of clearing time and describe an example of how this method
can be used to identify the best clearing time for 1mm-thick
cerebellar slices obtained from L7GFPmice, in which GFP (green
fluorescent protein) expression is driven by the Pcp-2 promoter
and is specific for Purkinje cells (PCs) in the cerebellar layers
(Zhang et al., 2001). In parallel, to double-check our experimental
method, the results were compared with those obtained with
indexes usually used in image processing.
MATERIALS AND METHODS
Tissue Preparation
L7GFP and wild-type (WT) mice were obtained from the
Department of Translational Research, New Technologies in
Medicine and Surgery of the University of Pisa (Italy).
Mice were used to perform the experiments, which were
conducted in conformity with the European Communities
Council Directive of 24 November 1986 (86/609/EEC and
2010/63/UE) and in agreement with the Italian DM26/14.
Experiments were approved by the Italian Ministry of Health
and Ethical Committee of the University of Pisa. Adult mice
were anesthetized with a lethal dose of 7% chloral hydrate
and then perfused at a slow flow rate (about 2min for 20mL
of solution) with 20mL of ice cold Phosphate Buffered Saline
(PBS 1X, Sigma-Aldrich, Milan, Italy) and then 20mL of ice
cold hydrogel solution, containing 4% acrylamide, 0.05% bis-
acrylamide (Biorad Lab Inc., California, USA), 4% formaldehyde
(PFA, Sigma-Aldrich) and 0.25% VA-044 thermally triggered
initiator (Wako Chemicals, Neuss, Germany) at 4◦C, as described
in Chung et al. (2013). The brain was immediately extracted
and submerged in 20mL hydrogel solution for 3 days at 4◦C
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in a 50mL Falcon tube (covered with aluminum foil to protect
samples from direct light exposure) to allow gel diffusion into
the tissue. Then the cap was substituted with a modified one
with a small hole to which a short piece of silicone tube with
an on-off valve was hot-glued. A vacuum was applied to the
tube for 10min, after which the valve was closed to enable
hydrogel formation in the absence of air (the presence of oxygen
impedes gelation of the acrylamide gel). Polymerization of the
biomolecule-conjugated monomers in the hydrogel mesh was
thermally initiated by incubating the infused tissue overnight at
37◦C. At this point, the mouse brain was isolated by carefully
removing the surrounding excess hydrogel, and vertically cut
along to the coronal plane with a scalpel to obtain the portion
containing the cerebellum. The latter was then cut into 1mm-
thick coronal slices using a Leica VT1200S vibratome (Leica
Microsystems, Nussloch, Germany) with a stainless steel razor
blade (Gillette, Milan, Italy). The cut settings were: blade
angle, 18◦; sectioning speed, 0.2mm/s; and oscillating amplitude,
1.5mm (Mattei et al., 2015). Each hydrogel-embedded slice was
placed in a 50mL Falcon tube at 37◦C with 20mL of CLARITY
clearing solution, composed of 200mM Boric Acid (Farmitalia
Carlo Erba spa, Italy) and 4% Sodium Dodecyl Sulphate (SDS,
Sigma-Aldrich) (Chung et al., 2013). The pH was adjusted to 8.5
by adding 1M NaOH dropwise. Cerebellar slices embedded in
the hydrogel and immersed in 20mL of 1X PBS solution were
used as controls. Clearing solutions and PBS in the controls were
changed at 3, 5, and 7 days.
Quantitative Evaluation of Clarification
At each time point investigated (i.e., day 0− 3− 5− 7− 10), the
“goodness” of clarification for both the treated tissue slices and
controls was evaluated using two macroscopic approaches: (i) a
quantification of tissue clarification through image analysis, and
(ii) an evaluation of the fraction of the protein-of-interest lost in
the clearing solution.
Bulk Tissue Clarification Index
Tissue slices were placed on a white plastic support marked with a
black line and photographed using a Nikon D5100 reflex camera
(Figure 1). After converting the images into 8-bit grayscale, the
clarification was evaluated defining a Bulk Tissue Clarification
index (BTCi) as:
BTCi =
255− I1
255− Is
(1)
where I1 and Is are the mean pixel intensities of the black
line traced on the support respectively with and without
the tissue on it. Averaging the pixel intensities reduces local
variations, while the term Is in Equation 1 serves as an internal
normalization which eliminates variations due to any differences
in environmental light conditions between images. The index so-
defined ranges from 0 (i.e., totally opaque white slice) to 1 (i.e.,
totally transparent slice).
Quantification of the Fluorescent Protein Loss
In principle, there are two sources of tissue protein loss: protein
denaturation due to the clearing solution and protein release
in the clearing solution. Since the clearing solution (pH 8.5
FIGURE 1 | Photographs of cerebellar slices at different clearing times.
The images were used to calculate BTCi through Equation (1), comparing the
intensity of the black line below the slice and in the region without the slice.
(pixel size: 0.125mm).
containing SDS) is not likely to denature biological fluorophores
(Saeed and Ashraf, 2009), the loss of fluorescent protein from
the slice can be assumed equal to that released in the clearing
solution. In this study, to quantify GFP loss, at each time
point, 200 µL samples of the clearing solution were analyzed in
triplicate with a plate reader (FLUOstar Omega, BMG Labtech,
Ortenberg, Germany, Ex: 485 nm and Em: 544 nm). Fluorescence
was read against a blank of fresh clearing solution, keeping
the spectrofluorimeter settings (e.g., gain, number of flashes
per well) constant over measurements to enable meaningful
quantitative analyses of fluorescent protein release over time.
Since the clearing solution was completely refreshed at day 3,
5, and 7, for each brain slice the fluorescence data obtained at
different time points were summed and expressed as cumulative
fluorescence until day 10. To exclude fluorescent contributions
due to tissue degradation or autofluorescence, no-labeled tissue
slices were also clarified and clearing solution samples were taken
at the same time points (i.e., day 3–5–7–10) analyzed with the
same plate-reader settings.
Evaluation of Image Quality Using
Standard Indices
Image stacks of slices treated with clearing solution and controls
were mounted on a glass slide with FocusClearTM (Celexplorer
Labs Co., Hsinchu, Taiwan) and then acquired with a confocal
microscope (Nikon A1) at different time points. In particular,
a 200µm z-stack with a step size of 2µm was acquired using
a 10X objective with a pixel-to-micron ratio of 0.46µm/pixel
on a 512 × 512 matrix. The same confocal settings were used
for all scans (i.e., 4.84 W laser power, emission and excitation
wavelengths of 488 nm and 502 nm respectively). Two widely
used indices for quantifying image quality were calculated:
(i) Mean Pixel Intensity
To quantify tissue clarification as function of time, theMean Pixel
Intensity (MPI) of the objects of interest (PCs) was evaluated
using the method described by Gonzalez et al. (2009). An
automated algorithm was developed in Matlab (The Mathworks
Inc.) to estimate the MPI for each of the 100 images in the z-
stack. First a global threshold with Otsu’s method (Otsu, 1979)
was performed for every plane image of the stack to identify the
objects (i.e., the PCs). Then, the MPI of thresholded objects in
each plane was calculated using:
MPI =
∑i=M
i= 1 IM
M
(2)
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FIGURE 2 | (A) BTCi as a function of clearing time for control cerebellar slices in PBS (n = 5, red) and in CLARITY clearing solution (n = 5, blue) slices. (B) Cumulative
GFP measured in the clearing solution over time (n = 5 slices). (C) Fraction of GFP retained (GFPfr ), expressed as in equation 4, showing no significant differences
between slices at the same time point. (D) BTCi and GFPfr time series obtained grouping results from the 5 different slices together, showing the relationship between
the two parameters.
where M is the number of object pixels and IM their pixel
intensity.
(ii) Contrast-to-Noise Ratio (CNR)
Although, the MPI is a measure of the signal, it is not
directly linked to the information content of the image, which
also depends on contrast between labeled neurons and the
background. An alternative parameter for evaluating light
scattering through the depth of the slice taking into account
the image background is the Contrast-to-Noise (CNR) ratio
defined as:
CNR=
MPI−Ib√
σm+σb
2
(3)
where MPI is as defined previously, Ib is the mean intensity of
the background, σm is the standard deviation of the objects and
σb the standard deviation of the background (Song et al., 2004).
Once again, the CNR was calculated using an automated
routine in Matlab. For each image in the stack, the Otsu-based
thresholding method described was used to identify the objects
of interest and discriminate them from the background. Then,
assuming σm = σb, as proposed by Song and co-workers (Song
et al., 2004), the CNR was calculated according to Equation (3).
Sample Evaluation and Statistical Analysis
Five animals were employed for theMPI andCNR analyses, using
n = 2 slices per day for both experimental samples and controls.
Thus, a total of n = 18 slices were employed, 2 for the time 0
analyses and 16 for the other time-points, i.e., 2 (replicates) ×
4 (time points) × 2 (treatments). Each sample was imaged in 4
different regions, thus averaging 8 datasets from 2 slices per data
point. Sample from different animals were pooled together as
replicates for the analyses, assuming no inter-animal differences.
Six animals, three L7GFP mice and three WTs, were used for
the macroscale BTCi and protein loss experiments, again pooling
samples together. Here a total of n = 10 slices (5 controls in
PBS + 5 samples in clearing solution) were used throughout
the 10 days to determine average daily values of BTCi and
GFP leakage. Unlike the MPI and CNR analyses, BTCi and
GFP loss experiments were performed on the same slice until
day 10, obtaining 5 replicates per experiment and time point
investigated.
Statistical analyses of BTCi, GFP loss, MPI, and CNR data
were carried out using ANOVA followed by Tukey’s Multiple
Comparison Test, setting significance at p < 0.05.
RESULTS
Bulk Tissue Clarification Index (BTCi)
Evaluation
Assuming no differences in the gross optical properties between
cerebellum slices, data from different sections acquired at the
same time points were grouped together as sample replicates to
evaluate the BTCi.
The initial BTCi for untreated slices (i.e., time 0 in Figure 2A)
was 0.43 ± 0.04. For samples immersed in clearing solution,
this index increases significantly over time (p > 0.05, one-way
ANOVA) until it reaches a plateau at day 5 (BTCi = 0.88± 0.11).
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FIGURE 3 | (A) Mean pixel intensity (MPI) as a function of stack depth for tissue slices immersed in clearing solution for different times (n = 2 slices per line). (B) MPI
for controls (n = 2 slices per line). (C) CNR (contrast to noise ratio) as a function of stack depth for tissue slices immersed in clearing solution for different times (n = 2
slices per line). (D) MPI for controls (n = 2 slices per line). For each sample acquired, the MPI and CNR were calculated over 200µm thick regions from 100 different
images spaced 2µm apart, i.e., a total of 100 data points).
On the other hand, the BTCi does not change significantly over
time (p > 0.05, one-way ANOVA) for cerebellar slices immersed
in PBS (i.e., the negative control).
Evaluation of GFP Fraction Lost
As fluorescence from un-labeled tissue slices was similar to
that of the virgin clearing solution, we can assume that there
are no fluorescent components from tissue degradation or
autofluorescence of brain components, and so all the signal
detected by the spectrofluorimetric analysis refers to GFP loss
in the clearing solution. The cumulative GFP loss from each
sample is reported in Figure 2B. Data for GFP loss in controls
are not shown as the values were either negative or close to zero,
indicating levels of GFP close to or below the limit of detection.
As shown in the figure, the rate of GFP leaked is initially
high but tends to decrease with time toward an equilibrium
value, typical of passive diffusion. Although, the trend for all
slices examined is similar, it is not possible to assume a slice-
independency as supposed for the BTCi evaluation. Indeed, the
amount of GFP leaked into the clearing solution, expressed as
arbitrary fluorescence units, varies from slice to slice because
of the heterogeneous distribution of PCs in the cerebellum
(Figure 2B). Hence an appropriate normalization is needed to
meaningfully compare results from different slices. Assuming
GFP loss is a diffusive process, each sample loses the same
fraction of protein at equilibrium. Since the cumulative GFP
release did not change significantly between day 7 and 10 (i.e.,
the release of GFP appears to have reached a plateau and does
not increase significantly over time), we assume that day 10
corresponds to the equilibrium state. Therefore, to normalize the
loss of fluorescent protein (FPloss) from each slice, the cumulative
fluorescence values obtained from the clearing solutions were
divided by their respective values at day 10, FPloss(tend). A first
one-way ANOVA analysis was performed on normalized GFP
data obtained at each of the time points investigated to verify
that this parameter is not slice-dependent (Figure 2C). Then,
data from different slices collected at the same time point were
grouped together to give the fraction of fluorescent protein
retained, FPfr :
FPfr (t) = 1−
FPloss(t)
FPloss (tend)
(4)
The fraction of fluorescent protein retained decreases
continuously over time, as expected for passive diffusion
(Figure 2D). The corresponding BTCi is plotted in the same
graph to highlight the correlation between tissue transparency
and GFP specific fluorescence of the sample.
MPI and CNR Evaluation
The image based MPI and CNR analyses of the confocal z-stack
images are reported in Figure 3. For the sake of clarity, only
the mean values are shown. Although, the variations are not
statistically significant due to the unavoidable intrinsic variations
between slices and the heterogeneous distribution of cells in each
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FIGURE 4 | Volume view of a confocal stack acquired at day 5 (Ex/Em:
488/502, pixel-to micron ratio: 0.62µm, z-resolution: 1.2µm). Volume
dimensions (w × l × h): 317× 317 × 172µm (numbers in the edges of the box
represent distances in microns).
region imaged, there is a notable difference in trends between
the samples immersed in the CLARITY clearing solution and
PBS. The MPI decreases with increasing depth in controls and
this trend is fairly independent of the number of days the
slice is immersed in PBS (Figure 3B). On the other hand, in
clarified tissues the MPI decreases with depth during the first
few days in clearing solution and then increases inside the slices,
reaching the highest values at day 5 (Figure 3A). Similar results
are obtained for the CNR (Figure 3C for the slices immersed in
clearing solution and Figure 3D for the PBS-immersed ones); for
a given depth in the sample the highest CNR values are found
at day 5 of clarification. Figure 4 shows a volume view of a 3D
reconstruction from a confocal stack acquired at day 5, while
Video 1 (see Supplementary Materials) is an animation of the
cerebellum slice.
DISCUSSION
Most investigations on the optimization of CLARITY and its
variants focus on the composition of the hydrogel embedding and
clearing solutions and on design of the electrophoretic chamber.
Whatever the method and reagents used, the “goodness” of
any clearing process is essentially the best trade-off between
tissue transparency and the presence of molecules of interest to
imaging. For a given clearing cocktail, the former increases with
clearing time, while the latter are inevitably lost due to a shift
in equilibrium between tissue bound and unbound moieties or
protein degradation. The aim of this study was therefore to design
a method to characterize the clearing process as a function of
time and so determine the optimum clearing time for thick brain
slices.
The approach described was applied to 1mm-thick
cerebellum slices of L7GFP mice, whose Purkinje neurons
are fluorescent labeled, using the diffusion-based CLARITY2
method. The “goodness” of clarification was quantified by
evaluating both the bulk tissue clarification index (BTCi) and
the fraction of GFP lost in the clearing solution. Figure 2D
summarizes the main results of the macroscale analyses: BTCi
increases with clearing time, reaching a plateau after 5 days,
while the fraction of GFP retained decreases rapidly. To attest
the validity of the approach, brain slices were also imaged using
confocal microscopy to calculate the MPI of neurons and the
CNR as a function of z-stack depth. The results show that slices
cleared for 5 days have the highest MPI and CNR for the widest
range of depths. This trend is not observed for PBS-immersed
slices.
Thus, the delipidation time can be optimized by measuring
the bulk tissue clarification index and the fraction of protein-of-
interest lost in clearing solution simultaneously. The optimum
clearing time is when tissue clarification just reaches its
maximum, as any further clearing leads to excessive and
useless signal loss. Prolonging the clarification treatment does
not significantly improve tissue transparency and may also be
detrimental for the maintenance of the sample’s architectural
and biochemical features. In case of fluorescent proteins less
stable than GFP and its relatives, or for non-genetically labeled
tissues, the latter can be measured with different complementary
techniques (i.e., the BCA (bicinchoninic acid) protein assay),
assuming the all the proteins behave in the same way during the
diffusion processes).
The approach proposed in this paper can be generalized and
adopted for the quantification and optimization of other optical
clearing methods (e.g., 3Ddisco, PACT etc.) and/or different
organs, animals or sample size.
Once sufficient lipids have been removed to attenuate
scattering [the main cause of tissue opacity (Jacques, 2013)]
without compromising protein loss, Focus Clear or alternative
solutions with a high real (i.e., n) and low imaginary
refractive index (i.e., jk or attenuation coefficient) can increase
tissue transparency post-clearing as recently demonstrated by
Costantini et al. (2015).
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